Polymedix, Inc. 

PA

  SEC # 1341843

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  10/19/05   —   First EDGAR Filing:  10/19/05   –   Last Filing:  9/10/15  (None in the Past Year) 

Business Address      On:  9/10/15       [ Map ]		Mailing Address      On:  9/10/15       [ Map ]
170 N. Radnor-Chester Road Suite 300 Radnor, Pennsylvania  19087 U.S.A.

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 484-598-2370		Delaware, U.S.A.		12/31/yy		27-0125925		0001341843		000-51895

Industry Classification
SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 2834 Pharmaceutical Preparations 2015 SEC Office of Life Sciences

        

Management
Director   In   PA   Landekic Nicholas 2006-2012   CT   Lewis Michael E 2006-2012   PA   O Malley Shaun 2006-2012   UT   Anderson Brian 2008-2012   CA   Bank Richard W 2008-2012   CA   Loren Stefan 2008-2012   MD   Swirsky Douglas J 2009-2012   PA   Slattery Frank P Jr. 2006-2011   NJ   Kelley Willam N 2006-2009 ↓List Pre-2008 Directors				Officer  Since  Most-Recent Title   In   PA   Jorgensen Daniel 2011 Sr VP Clinical Dev & CMO 2012   PA   Korczak Bozena 2007 VP Drug Development 2012   PA   Landekic Nicholas 2006 CEO 2012   PA   Scott Richard W 2006 VP Research 2012   PA   Smith Edward F 2006 CFO 2012   PA   Helmling Steffen A. VP of Business Development 2010   MA   McAllister R Eric 2007 VP Clin.Dev., Ch.Med.Officer 2010   PA   Ford James Gregory 2008 VP of Business Development 2009 ↓List Pre-2008 Officers

        

        

        

        

Securities
CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2020:   73174C 73174C·10·0     Common 73174C·30·8     Common _________  Classes source:  Form 13F Filings that list Section 13(f) Securities